DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
6532
CP-547,632
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
CP-547,632
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BUCINDOLOL
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BUCINDOLOL
×
Maximum Phase:
2
First Approval:
None
UNII:
E9UO06K7CE
Molecule Type:
Small molecule
Molecular Formula:
C22H25N3O2
Molecular Weight:
363.46
AlogP:
3.39
PSA:
81.07
HBD:
3.0
HBA:
#RotB:
8.0
Source:
BEFIRADOL
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Serotonin 1a (5-HT1a) receptor agonist
BEFIRADOL
×
Maximum Phase:
2
First Approval:
None
UNII:
RAT9OHA1YH
Molecule Type:
Small molecule
Molecular Formula:
C20H22ClF2N3O
Molecular Weight:
393.87
AlogP:
3.92
PSA:
45.23
HBD:
1.0
HBA:
#RotB:
5.0
Source:
PELITINIB
2
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Carcinoma, Non-Small-Cell Lung; Colonic Neoplasms; Rectal Neoplasms
Epidermal growth factor receptor erbB1 inhibitor
PELITINIB
×
Maximum Phase:
2
First Approval:
None
UNII:
X5DWL380Z6
Molecule Type:
Small molecule
Molecular Formula:
C24H23ClFN5O2
Molecular Weight:
467.93
AlogP:
5.1
PSA:
90.28
HBD:
2.0
HBA:
#RotB:
8.0
Source:
GSK-364735
2
Small molecule
Investigational
Unknown
Unknown
HIV Infections
Human immunodeficiency virus type 1 integrase inhibitor
GSK-364735
×
Maximum Phase:
2
First Approval:
None
UNII:
SXN0KXT60S
Molecule Type:
Small molecule
Molecular Formula:
C19H18FN3O4
Molecular Weight:
371.37
AlogP:
1.09
PSA:
104.45
HBD:
3.0
HBA:
#RotB:
5.0
Source:
ABT-639
2
Small molecule
Investigational
Unknown
Unknown
Neuralgia
Voltage-gated T-type calcium channel alpha-1H subunit blocker
ABT-639
×
Maximum Phase:
2
First Approval:
None
UNII:
0G7D0CQ88I
Molecule Type:
Small molecule
Molecular Formula:
C20H20ClF2N3O3S
Molecular Weight:
455.91
AlogP:
3.34
PSA:
69.72
HBD:
1.0
HBA:
#RotB:
4.0
Source:
NIVOCASAN
2
Small molecule
Investigational
Unknown
Unknown
Hepatitis C; Non-alcoholic Fatty Liver Disease
Caspase-1 inhibitor
NIVOCASAN
×
Maximum Phase:
2
First Approval:
None
UNII:
9554OW6MVU
Molecule Type:
Small molecule
Molecular Formula:
C21H22FN3O5
Molecular Weight:
415.42
AlogP:
1.84
PSA:
110.11
HBD:
2.0
HBA:
#RotB:
5.0
Source:
POLIFEPROSAN 20
2
Small molecule
Investigational
Unknown
Unknown
Central Nervous System Neoplasms
Unknown
POLIFEPROSAN 20
×
Maximum Phase:
2
First Approval:
None
UNII:
S40C40DA21
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AZD7325
2
Small molecule
Investigational
Unknown
Unknown
Fragile X Syndrome; Anxiety; Child Development Disorders, Pervasive
GABA receptor alpha-2 subunit positive allosteric modulator
AZD7325
×
Maximum Phase:
2
First Approval:
None
UNII:
KNM216XOUH
Molecule Type:
Small molecule
Molecular Formula:
C19H19FN4O2
Molecular Weight:
354.39
AlogP:
3.17
PSA:
90.13
HBD:
2.0
HBA:
#RotB:
5.0
Source:
RICOLINOSTAT
2
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms; Klatskin Tumor; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma; Multiple Myeloma; Diabetic Neuropathies
Histone deacetylase 6 inhibitor
RICOLINOSTAT
×
Maximum Phase:
2
First Approval:
None
UNII:
WKT909C62B
Molecule Type:
Small molecule
Molecular Formula:
C24H27N5O3
Molecular Weight:
433.51
AlogP:
4.13
PSA:
107.45
HBD:
3.0
HBA:
#RotB:
11.0
Source:
ICOSABUTATE
2
Small molecule
Investigational
Unknown
Unknown
Lipid Metabolism Disorders; Non-alcoholic Fatty Liver Disease
Unknown
ICOSABUTATE
×
Maximum Phase:
2
First Approval:
None
UNII:
562599X5JL
Molecule Type:
Small molecule
Molecular Formula:
C24H38O3
Molecular Weight:
374.57
AlogP:
6.79
PSA:
46.53
HBD:
1.0
HBA:
#RotB:
17.0
Source:
BENTAMAPIMOD
2
Small molecule
Investigational
Unknown
Unknown
Endometriosis
c-Jun N-terminal kinase, JNK inhibitor
BENTAMAPIMOD
×
Maximum Phase:
2
First Approval:
None
UNII:
TT3L4B4U0N
Molecule Type:
Small molecule
Molecular Formula:
C25H23N5O2S
Molecular Weight:
457.56
AlogP:
4.15
PSA:
84.16
HBD:
0.0
HBA:
#RotB:
7.0
Source:
FLAVONE
2
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms
Unknown
FLAVONE
×
Maximum Phase:
2
First Approval:
None
UNII:
S2V45N7G3B
Molecule Type:
Small molecule
Molecular Formula:
C15H10O2
Molecular Weight:
222.24
AlogP:
3.46
PSA:
30.21
HBD:
0.0
HBA:
#RotB:
1.0
Source:
ADRIFORANT
2
Small molecule
Investigational
Unknown
Unknown
Asthma; Dermatitis, Atopic; Psoriasis
Histamine H4 receptor antagonist
ADRIFORANT
×
Maximum Phase:
2
First Approval:
None
UNII:
D65H9YE9VU
Molecule Type:
Small molecule
Molecular Formula:
C13H22N6
Molecular Weight:
262.36
AlogP:
0.68
PSA:
79.1
HBD:
3.0
HBA:
#RotB:
5.0
Source:
VAPITADINE DIHYDROCHLORIDE
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Histamine H1 receptor antagonist
VAPITADINE DIHYDROCHLORIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
R612XR8A9F
Molecule Type:
Small molecule
Molecular Formula:
C17H22Cl2N4O
Molecular Weight:
369.3
AlogP:
1.21
PSA:
72.94
HBD:
2.0
HBA:
#RotB:
1.0
Source:
PALIRODEN
2
Small molecule
Investigational
Unknown
Unknown
Alzheimer Disease; Parkinson Disease
Unknown
PALIRODEN
×
Maximum Phase:
2
First Approval:
None
UNII:
17VJ76L90T
Molecule Type:
Small molecule
Molecular Formula:
C26H24F3N
Molecular Weight:
407.48
AlogP:
6.7
PSA:
3.24
HBD:
0.0
HBA:
#RotB:
5.0
Source:
BMS-986094
2
Small molecule
Investigational
Unknown
Unknown
Hepatitis C
Hepatitis C virus NS5B RNA-dependent RNA polymerase inhibitor
BMS-986094
×
Maximum Phase:
2
First Approval:
None
UNII:
62F4AD749Y
Molecule Type:
Small molecule
Molecular Formula:
C30H39N6O9P
Molecular Weight:
658.65
AlogP:
3.35
PSA:
202.4
HBD:
4.0
HBA:
#RotB:
11.0
Source:
IBERDOMIDE HYDROCHLORIDE
2
Small molecule
Investigational
Unknown
Unknown
Liver Diseases; Lymphoma; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lupus Erythematosus, Systemic; Sarcoidosis; Smoldering Multiple Myeloma; Multiple Myeloma
Unknown
IBERDOMIDE HYDROCHLORIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
79L3645KFI
Molecule Type:
Small molecule
Molecular Formula:
C25H28ClN3O5
Molecular Weight:
485.97
AlogP:
1.86
PSA:
88.18
HBD:
1.0
HBA:
#RotB:
6.0
Source:
ALVESPIMYCIN
2
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms
Heat shock protein HSP90 inhibitor
ALVESPIMYCIN
×
Maximum Phase:
2
First Approval:
None
UNII:
001L2FE0M3
Molecule Type:
Small molecule
Molecular Formula:
C32H48N4O8
Molecular Weight:
616.76
AlogP:
1.91
PSA:
169.52
HBD:
4.0
HBA:
#RotB:
7.0
Source:
FLUBROBENGUANE F18
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
FLUBROBENGUANE F18
×
Maximum Phase:
2
First Approval:
None
UNII:
8LF7W971UM
Molecule Type:
Small molecule
Molecular Formula:
C11H15BrFN3O
Molecular Weight:
303.17
AlogP:
2.17
PSA:
71.13
HBD:
3.0
HBA:
#RotB:
6.0
Source:
ELVUCITABINE
2
Small molecule
Investigational
Unknown
Unknown
Hepatitis B, Chronic; HIV Infections
DNA polymerase/reverse transcriptase inhibitor
ELVUCITABINE
×
Maximum Phase:
2
First Approval:
None
UNII:
M09BUF90C0
Molecule Type:
Small molecule
Molecular Formula:
C9H10FN3O3
Molecular Weight:
227.19
AlogP:
-0.59
PSA:
90.37
HBD:
2.0
HBA:
#RotB:
2.0
Source:
QLT0074
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
QLT0074
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
UR-63325
2
Small molecule
Investigational
Unknown
Unknown
Rhinitis, Allergic, Seasonal
Histamine H4 receptor antagonist
UR-63325
×
Maximum Phase:
2
First Approval:
None
UNII:
B61N8R7TDH
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GC-4711
2
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung; Pancreatic Neoplasms
Unknown
GC-4711
×
Maximum Phase:
2
First Approval:
None
UNII:
FW5T90VM32
Molecule Type:
Small molecule
Molecular Formula:
C27H45MnN5O4
Molecular Weight:
558.63
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
PCS-499
2
Small molecule
Investigational
Unknown
Unknown
Diabetic Nephropathies; Renal Insufficiency, Chronic; Necrobiosis Lipoidica
Unknown
PCS-499
×
Maximum Phase:
2
First Approval:
None
UNII:
FLV771E8ZV
Molecule Type:
Small molecule
Molecular Formula:
C13H20N4O3
Molecular Weight:
285.36
AlogP:
-0.02
PSA:
82.05
HBD:
1.0
HBA:
#RotB:
5.0
Source:
HEMOGLOBIN GLUTAMER
2
Small molecule
Investigational
Unknown
Unknown
Coronary Disease; Peripheral Vascular Diseases
Unknown
HEMOGLOBIN GLUTAMER
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RUTIN
2
Small molecule
Investigational
Unknown
Unknown
Cardiovascular Diseases; Prostatic Neoplasms, Castration-Resistant
Unknown
RUTIN
×
Maximum Phase:
2
First Approval:
None
UNII:
5G06TVY3R7
Molecule Type:
Small molecule
Molecular Formula:
C27H30O16
Molecular Weight:
610.52
AlogP:
-1.69
PSA:
269.43
HBD:
10.0
HBA:
#RotB:
6.0
Source:
AFEGOSTAT TARTRATE
2
Small molecule
Investigational
Unknown
Unknown
Gaucher Disease
Beta-glucocerebrosidase stabiliser
AFEGOSTAT TARTRATE
×
Maximum Phase:
2
First Approval:
None
UNII:
285ZJJ9773
Molecule Type:
Small molecule
Molecular Formula:
C10H19NO9
Molecular Weight:
297.26
AlogP:
-2.08
PSA:
72.72
HBD:
4.0
HBA:
#RotB:
1.0
Source:
PRATOSARTAN
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Solute carrier family 22 member 12 inhibitor
PRATOSARTAN
×
Maximum Phase:
2
First Approval:
None
UNII:
66VLQ6E6DL
Molecule Type:
Small molecule
Molecular Formula:
C25H26N6O
Molecular Weight:
426.52
AlogP:
4.64
PSA:
89.35
HBD:
1.0
HBA:
#RotB:
6.0
Source:
A-002
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
A-002
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
P
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
P
×
Maximum Phase:
2
First Approval:
None
UNII:
N939YFB9KP
Molecule Type:
Small molecule
Molecular Formula:
C13H20N4O3
Molecular Weight:
280.33
AlogP:
-0.02
PSA:
82.05
HBD:
1.0
HBA:
#RotB:
5.0
Source:
RADIPRODIL
2
Small molecule
Investigational
Unknown
Unknown
Neuralgia; Spasms, Infantile
Glutamate NMDA receptor; GRIN1/GRIN2B antagonist
RADIPRODIL
×
Maximum Phase:
2
First Approval:
None
UNII:
5XGC17ZKUF
Molecule Type:
Small molecule
Molecular Formula:
C21H20FN3O4
Molecular Weight:
397.41
AlogP:
2.68
PSA:
95.41
HBD:
2.0
HBA:
#RotB:
3.0
Source:
CR 1447
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Androgen Receptor agonist
CR 1447
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BTRX-335140
2
Small molecule
Investigational
Unknown
Unknown
Depressive Disorder, Major
Kappa opioid receptor antagonist
BTRX-335140
×
Maximum Phase:
2
First Approval:
None
UNII:
XK5ILZ28KI
Molecule Type:
Small molecule
Molecular Formula:
C25H32FN5O2
Molecular Weight:
453.56
AlogP:
4.34
PSA:
76.31
HBD:
1.0
HBA:
#RotB:
5.0
Source:
TARAFENACIN
2
Small molecule
Investigational
Unknown
Unknown
Urinary Bladder, Overactive
Muscarinic acetylcholine receptor M3 antagonist
TARAFENACIN
×
Maximum Phase:
2
First Approval:
None
UNII:
LDV98UN52Y
Molecule Type:
Small molecule
Molecular Formula:
C21H20F4N2O2
Molecular Weight:
408.39
AlogP:
4.48
PSA:
32.78
HBD:
0.0
HBA:
#RotB:
4.0
Source:
1
2
…
115
116
117
118
119
120
121
…
186
187
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA